These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
306 related items for PubMed ID: 30464693
1. Elective nodal irradiation or involved-field irradiation in definitive chemoradiotherapy for esophageal squamous cell cancer: a retrospective analysis in clinical N0 patients. Sun Y, Zhang XL, Mao QF, Liu YH, Kong L, Li MH. Curr Oncol; 2018 Oct; 25(5):e423-e429. PubMed ID: 30464693 [Abstract] [Full Text] [Related]
2. Comparison of involved field radiotherapy and elective nodal irradiation in combination with concurrent chemotherapy for T1bN0M0 esophageal cancer. Nakatani Y, Kato K, Shoji H, Iwasa S, Honma Y, Takashima A, Ushijima T, Ito Y, Itami J, Boku N. Int J Clin Oncol; 2020 Jun; 25(6):1098-1104. PubMed ID: 32189155 [Abstract] [Full Text] [Related]
3. Elective nodal irradiation versus involved-field irradiation in patients with esophageal cancer receiving neoadjuvant chemoradiotherapy: a network meta-analysis. Liu T, Ding S, Dang J, Wang H, Chen J, Li G. Radiat Oncol; 2019 Oct 16; 14(1):176. PubMed ID: 31619265 [Abstract] [Full Text] [Related]
4. Patterns of failure after involved field radiotherapy for locally advanced esophageal squamous cell carcinoma. Li DJ, Li HW, He B, Wang GM, Cai HF, Duan SM, Liu JJ, Zhang YJ, Cui Z, Jiang H. J BUON; 2016 Oct 16; 21(5):1268-1273. PubMed ID: 27837632 [Abstract] [Full Text] [Related]
5. Elective nodal irradiation versus involved-field irradiation for stage II-IV cervical esophageal squamous cell carcinoma patients undergoing definitive concurrent chemoradiotherapy: a retrospective propensity study with 8-year survival outcomes. Wang J, Wu Y, Zhang W, Chen Y, Liu Q, Jing S, Zhang J, Wu F, Wang J, Qiao X. Radiat Oncol; 2023 Aug 28; 18(1):142. PubMed ID: 37641149 [Abstract] [Full Text] [Related]
6. Concurrent chemoradiotherapyof different radiation doses and different irradiation fields for locally advanced thoracic esophageal squamous cell carcinoma: A randomized, multicenter, phase III clinical trial. Zhang J, Li M, Zhang K, Zheng A, Li G, Huang W, Chen S, Chen X, Li X, Sheng Y, Sun X, Liu L, Liu X, Li J, Wang J, Ge H, Ye S, Pang Q, Zhang X, Dai S, Yu R, Gu W, Dai M, Siqin G, Han Y, Ge X, Yuan X, Yang Y, Zhu H, Pu J, Dong L, Sun X, Zhou J, Mao W, Gao F, Lin H, Gong H, Zhou T, Li Z, Li H, Wang Z, Li B. Cancer Commun (Lond); 2024 Oct 28; 44(10):1173-1188. PubMed ID: 39161079 [Abstract] [Full Text] [Related]
7. Comparison between the effects of elective nodal irradiation and involved-field irradiation on long-term survival in thoracic esophageal squamous cell carcinoma patients: A prospective, multicenter, randomized, controlled study in China. Lyu J, Yisikandaer A, Li T, Zhang X, Wang X, Tian Z, Chen L, Lu B, Chen H, Yang J, Wang Q, Zhang J, Ma Y, Liu R, Liu R, Hage A, Lang J. Cancer Med; 2020 Oct 28; 9(20):7460-7468. PubMed ID: 32841543 [Abstract] [Full Text] [Related]
8. [Clinical outcomes of different irradiation ranges in definitive intensity-modulated radiotherapy for esophageal cancer]. Zhu SC, Li QF, Zhang XY, Deng WZ, Song CY, Wang X, Yan K. Zhonghua Zhong Liu Za Zhi; 2020 Dec 23; 42(12):1040-1047. PubMed ID: 33342161 [Abstract] [Full Text] [Related]
9. Feasibility of Elective Nodal Irradiation (ENI) and Involved Field Irradiation (IFI) in Radiotherapy for the Elderly Patients (Aged ≥ 70 Years) with Esophageal Squamous Cell Cancer: A Retrospective Analysis from a Single Institute. Jing W, Zhu H, Guo H, Zhang Y, Shi F, Han A, Li M, Kong L, Yu J. PLoS One; 2015 Dec 23; 10(12):e0143007. PubMed ID: 26636574 [Abstract] [Full Text] [Related]
10. Elective nodal irradiation provides a superior therapeutic modality for lymph node positivity esophageal squamous cell carcinoma patients receiving definitive radiotherapy versus involved-field irradiation. Li Q, Zhu S, Li S, Deng W. Medicine (Baltimore); 2019 Jan 23; 98(3):e14080. PubMed ID: 30653123 [Abstract] [Full Text] [Related]
11. Preliminary analysis of the benefits of different irradiation types on patients with postoperative locoregional recurrence of esophageal cell squamous carcinoma. Gao HM, Shen WB, Zhang XY, Xu JR, Li YM, Li SG, Zhu SC. Ann Palliat Med; 2021 Sep 23; 10(9):9467-9479. PubMed ID: 34628872 [Abstract] [Full Text] [Related]
12. Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma. Hsu FM, Lee JM, Huang PM, Lin CC, Hsu CH, Tsai YC, Lee YC, Chia-Hsien Cheng J. Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):e593-9. PubMed ID: 21658851 [Abstract] [Full Text] [Related]
13. Involved-Field Irradiation in Definitive Chemoradiotherapy for Locoregional Esophageal Squamous Cell Carcinoma: Results From the ESO-Shanghai 1 Trial. Zhu H, Rivin Del Campo E, Ye J, Simone CB, Zhu Z, Zhao W, Amini A, Zhou J, Wu C, Tang H, Fan M, Li L, Lin Q, Xia Y, Li Y, Li J, Mo M, Jia H, Lu S, Wang J, Nie Y, Chen J, Wu S, Hamaji M, Haque W, Jeong BK, Shridhar R, Zhang Z, Chen Y, Zhao K. Int J Radiat Oncol Biol Phys; 2021 Aug 01; 110(5):1396-1406. PubMed ID: 33677048 [Abstract] [Full Text] [Related]
16. Comparison of elective nodal irradiation and involved-field irradiation in esophageal squamous cell carcinoma: a meta-analysis. Cheng YJ, Jing SW, Zhu LL, Wang J, Wang L, Liu Q, Yang CR, Wang Y, Cao F, Jiao WP, Wu YJ. J Radiat Res; 2018 Sep 01; 59(5):604-615. PubMed ID: 30085197 [Abstract] [Full Text] [Related]
17. Definitive radiotherapy in patients with clinical T1N0M0 esophageal squamous cell carcinoma: A multicenter retrospective study (KROG 21-10). Song JY, Moon SH, Suh YG, Kim JH, Oh D, Noh JM, Jeong JU, Cho IJ, Kang MK, Kim JH, Kim YS, Kim HJ, Park WY, Kim BH, Kim HJ. Radiother Oncol; 2023 Dec 01; 189():109936. PubMed ID: 37783290 [Abstract] [Full Text] [Related]
20. A comparative study of elective nodal irradiation and involved field irradiation in elderly patients with advanced esophageal cancer. Dai Y, Huang D, Zhao W, Wei J. Front Oncol; 2023 Dec 01; 13():1323908. PubMed ID: 38173832 [Abstract] [Full Text] [Related] Page: [Next] [New Search]